Treatment of hypertension in patients with nondiabetic chronic kidney disease.

about

Hypertension in dialysis and kidney transplant patients.What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?Spatial distribution of kidney disease in the contaminated site of Taranto (Italy).

P2860

Q37253882-F6D2AA4A-E220-462B-A851-F1C7D5E484CB Q37925640-34DDC3F4-0485-49FE-9FFE-41777D879D27 Q48193619-A21566D4-FD5B-4967-B7AE-E1EDB8781A1F

P2860

Treatment of hypertension in patients with nondiabetic chronic kidney disease.

Item

http://www.wikidata.org/entity/Q36834063

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Treatment of hypertension in patients with nondiabetic chronic kidney disease.

@en

type

Item

label

Treatment of hypertension in patients with nondiabetic chronic kidney disease.

@en

prefLabel

Treatment of hypertension in patients with nondiabetic chronic kidney disease.

@en

P1476

Treatment of hypertension in patients with nondiabetic chronic kidney disease.

@en

P2093

Bruce Culleton

http://www.w3.org/2001/XMLSchema#string

Canadian Hypertension Education Program

http://www.w3.org/2001/XMLSchema#string

Kevin D Burns

http://www.w3.org/2001/XMLSchema#string

Marcel Ruzicka

http://www.w3.org/2001/XMLSchema#string

Sheldon W Tobe

http://www.w3.org/2001/XMLSchema#string

P2860

Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Chronic kidney disease and mortality risk: a systematic review

Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

Dyslipidemia and renal disease: pathogenesis and clinical consequences.

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

P304

595-601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0828-282X(07)70808-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sheldon W. Tobe

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17534470

http://www.w3.org/2001/XMLSchema#string

P932

2650767

http://www.w3.org/2001/XMLSchema#string

Treatment of hypertension in patients with nondiabetic chronic kidney disease.

about

P2860

P2860

Treatment of hypertension in patients with nondiabetic chronic kidney disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932